Compounds > verapamil

verapamil and aclacinomycin

verapamil has been researched along with aclacinomycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coley, HM; Twentyman, PR; Workman, P2
Dong, J; Johdo, O; Naito, M; Seimiya, H; Tatsuta, T; Tsuruo, T1

Other Studies

3 other study(ies) available for verapamil and aclacinomycin

ArticleYear
Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Biochemical pharmacology, 1989, Dec-15, Volume: 38, Issue:24

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cyclosporins; Doxorubicin; Drug Combinations; Drug Resistance; Humans; Mice; Tumor Cells, Cultured; Verapamil

1989
The efflux of anthracyclines in multidrug-resistant cell lines.
    Biochemical pharmacology, 1993, Oct-19, Volume: 46, Issue:8

    Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Mice; Phenotype; Tumor Cells, Cultured; Verapamil

1993
Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
    Oncology research, 1995, Volume: 7, Issue:5

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Nucleus; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblotting; Leukemia P388; Tumor Cells, Cultured; Verapamil; Vincristine

1995